Thyreos Inc.

Oak Park, IL

UEI
GFGNCMZKKLF7
CAGE
8U0N5
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Manufacturer of Goods
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
501 N Elmwood Ave, Oak Park, IL 60302, USA
Founded
2017
Employees
1-10
Estimated annual revenue
$0-$1M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
Bovine respiratory disease (BRD) is the leading cause of illness, death, and economic loss by infectious disease in the… 20253361044937 Institute of Food Production and Sustainability (NIFA) $174,699
An R2 non-neuroinvasive herpes simplex virus type 2 vaccine R42AI177202 National Institute of Allergy and Infectious Diseases (NIH) $3,288,038
Bovine alphaherpesvirus 1 (BOHV-1) is endemic in the USA cattle population and responsible for significant economic… 20223353037150 Institute of Food Production and Sustainability (NIFA) $174,235

Similar vendors

Vendor Location Primary NAICS
Solaris Vaccines, Inc. UEI G1P5NEDCERA9 Fort Collins, CO 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Applied Biotechnology Institute Inc. UEI XNMLFC55AWN3 San Luis Obispo, CA 541714 Research and Development in Biotechnology (except Nanobiotechnology)
Invvax, Inc. UEI XD11NMF7NB14 Cypress, CA 541714 Research and Development in Biotechnology (except Nanobiotechnology)
Carogen Corp UEI JNMNVKEUU2Y3 Hamden, CT 541714 Research and Development in Biotechnology (except Nanobiotechnology)
Tendel Therapies Inc. UEI JA9BDUH73852 Kensington, CA 541714 Research and Development in Biotechnology (except Nanobiotechnology)

See more similar vendors on GovTribe

About the company

Written by GovTribe AI ·

Thyreos Inc. is a for-profit corporate entity based in Oak Park, Illinois, registered in SAM.gov since December 2023 with an active registration until May 2026. The company appears to be a biotechnology and vaccine development firm specializing in innovative vaccine platforms, with a particular focus on developing advanced viral vaccines for both animal and human health applications. Its core technological approach centers on the R2 vaccine platform, which creates non-neuroinvasive vaccines that prevent viral pathogens from establishing lifelong infections in nervous systems while maintaining strong immunogenic responses.

Through federal grant awards, Thyreos Inc. has secured multiple project grants from agencies including the U.S. Department of Agriculture's National Institute of Food and Agriculture (NIFA) and the National Institute of Allergy and Infectious Diseases. The company's grant-funded research has concentrated on developing sophisticated vaccines targeting specific viral challenges, including a $174,699 grant to create an integrated vaccine protecting cattle against Bovine Respiratory Disease by expressing protective antigens from multiple viruses, and another grant focused on developing a non-neuroinvasive Herpes Simplex Virus Type 2 vaccine. These projects demonstrate Thyreos' expertise in engineering complex vaccine solutions that address significant health challenges in veterinary and human medical domains, utilizing their proprietary R2 technology platform to create safer, more effective vaccine candidates with improved immunological profiles compared to traditional vaccine designs.

Quick answers

Is Thyreos Inc. registered in SAM.gov?

Yes. Thyreos Inc.'s SAM.gov registration is active through July 29, 2027.

What is Thyreos Inc.'s CAGE code?

Thyreos Inc.'s CAGE code is 8U0N5, and its Unique Entity ID (UEI) is GFGNCMZKKLF7.

What is Thyreos Inc.'s most recent federal award?

Thyreos Inc.'s most recent federal grant award is Bovine respiratory disease (BRD) is the leading cause of illness, death, and economic loss by infectious disease in the… (20253361044937), from Institute of Food Production and Sustainability (NIFA), on August 15, 2025.

On GovTribe

See Thyreos Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login

Find teaming partners on GovTribe